Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin.

Ubiquitin conjugation (ubiquitylation) plays important roles not only in protein degradation but also in many other cellular functions. However, the sites of proteins that are targeted for such modification have remained poorly characterized at the proteomic level. We have now developed a method for the efficient identification of ubiquitylation sites in target proteins with the use of an engineered form of ubiquitin (K0-Ub), in which all seven lysine residues are replaced with arginine. K0-Ub is covalently attached to lysine residues of target proteins via an isopeptide bond, but further formation of a polyubiquitin chain does not occur on K0-Ub. We identified a total of 1392 ubiquitylation sites of 794 proteins from HEK293T cells. Profiling of ubiquitylation sites indicated that the sequences surrounding lysine residues targeted for ubiquitin conjugation do not share a common motif or structural feature. Furthermore, we identified a critical ubiquitylation site of the cyclin-dependent kinase inhibitor p27(Kip1). Mutation of this site thus inhibited ubiquitylation of and stabilized p27(Kip1), suggesting that this lysine residue is the target site of p27(Kip1) for ubiquitin conjugation in vivo. In conclusion, our method based on K0-Ub is a powerful tool for proteome-wide identification of ubiquitylation sites of target proteins.

[1]  Toshihide Nishimura,et al.  Large‐scale analysis of the human ubiquitin‐related proteome , 2005, Proteomics.

[2]  Lan Huang,et al.  Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. , 2008, Journal of proteome research.

[3]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[4]  Christine Yu,et al.  Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies , 2008, Cell.

[5]  E. Seto,et al.  Lysine acetylation: codified crosstalk with other posttranslational modifications. , 2008, Molecular cell.

[6]  Samie R Jaffrey,et al.  Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling , 2010, Nature Biotechnology.

[7]  K. Nakayama,et al.  CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis , 2009, Nature Cell Biology.

[8]  Guo-Ping Zhao,et al.  Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux , 2010, Science.

[9]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[10]  K. Resing,et al.  Mapping protein post-translational modifications with mass spectrometry , 2007, Nature Methods.

[11]  Tony Kouzarides,et al.  Acetylation: a regulatory modification to rival phosphorylation? , 2000, The EMBO journal.

[12]  K. Nakayama,et al.  Ubiquitin ligases: cell-cycle control and cancer , 2006, Nature Reviews Cancer.

[13]  Daniel Figeys,et al.  Proteomic analysis of ubiquitinated proteins from human MCF-7 breast cancer cells by immunoaffinity purification and mass spectrometry. , 2005, Journal of proteome research.

[14]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[15]  A. Ciechanover,et al.  Ubiquitin as a central cellular regulator , 2004, Cell.

[16]  S. Akira,et al.  Involvement of linear polyubiquitylation of NEMO in NF-κB activation , 2009, Nature Cell Biology.

[17]  K. Nakayama,et al.  U Box Proteins as a New Family of Ubiquitin-Protein Ligases* , 2001, The Journal of Biological Chemistry.

[18]  M. Mann,et al.  Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.

[19]  Masaru Tomita,et al.  emPAI Calc - for the estimation of protein abundance from large-scale identification data by liquid chromatography-tandem mass spectrometry , 2010, Bioinform..

[20]  M. Kitagawa,et al.  Down-regulation of p27 Kip1 by Two Mechanisms, Ubiquitin-mediated Degradation and Proteolytic Processing* , 1999, The Journal of Biological Chemistry.

[21]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[22]  C. Pickart,et al.  Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.

[23]  D. Reinberg,et al.  The Polycomb complex PRC2 and its mark in life , 2011, Nature.

[24]  Martin Scheffner,et al.  Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade , 1995, Nature.

[25]  Thibault Mayor,et al.  Analysis of Polyubiquitin Conjugates Reveals That the Rpn10 Substrate Receptor Contributes to the Turnover of Multiple Proteasome Targets*S , 2005, Molecular & Cellular Proteomics.

[26]  Jaclyn R. Gareau,et al.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition , 2010, Nature Reviews Molecular Cell Biology.

[27]  S. Gygi,et al.  A Perturbed Ubiquitin Landscape Distinguishes Between Ubiquitin in Trafficking and in Proteolysis* , 2011, Molecular & Cellular Proteomics.

[28]  C. Semple,et al.  The comparative proteomics of ubiquitination in mouse. , 2003, Genome research.

[29]  Yi Tang,et al.  Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. , 2011, Molecular cell.

[30]  Erica S. Johnson,et al.  Protein modification by SUMO. , 2004, Annual review of biochemistry.

[31]  Jun Qin,et al.  A Data Set of Human Endogenous Protein Ubiquitination Sites* , 2010, Molecular & Cellular Proteomics.

[32]  Steven P Gygi,et al.  A proteomics approach to understanding protein ubiquitination , 2003, Nature Biotechnology.

[33]  Shwu‐Yuan Wu,et al.  Crosstalk between sumoylation and acetylation regulates p53‐dependent chromatin transcription and DNA binding , 2009, The EMBO journal.

[34]  R. Watson,et al.  The epigenome as a therapeutic target in prostate cancer , 2010, Nature Reviews Urology.

[35]  M. Mann,et al.  Decoding signalling networks by mass spectrometry-based proteomics , 2010, Nature Reviews Molecular Cell Biology.

[36]  R. Hay,et al.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.

[37]  M. Ohh,et al.  NEDD8 pathways in cancer, Sine Quibus Non. , 2011, Cancer cell.

[38]  L. Jensen,et al.  Mass Spectrometric Analysis of Lysine Ubiquitylation Reveals Promiscuity at Site Level* , 2010, Molecular & Cellular Proteomics.

[39]  Pierre Baldi,et al.  A Tandem Affinity Tag for Two-step Purification under Fully Denaturing Conditions , 2006, Molecular & Cellular Proteomics.

[40]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[41]  Christine Yu,et al.  K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. , 2010, Molecular cell.

[42]  K. Nakayama,et al.  Preferential interaction of TIP120A with Cul1 that is not modified by NEDD8 and not associated with Skp1. , 2003, Biochemical and biophysical research communications.

[43]  Yixue Li,et al.  Regulation of Cellular Metabolism by Protein Lysine Acetylation , 2010, Science.

[44]  Jun Wu,et al.  Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells , 2008, Proteomics.

[45]  R. Aebersold,et al.  Direct identification of a G protein ubiquitination site by mass spectrometry. , 2002, Biochemistry.

[46]  V. Lang,et al.  Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin‐binding entities , 2009, EMBO reports.

[47]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[48]  Keiji Tanaka,et al.  A ubiquitin ligase complex assembles linear polyubiquitin chains , 2006, The EMBO journal.

[49]  Efterpi Papouli,et al.  Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. , 2005, Molecular cell.

[50]  Junmin Peng,et al.  Dissecting the ubiquitin pathway by mass spectrometry. , 2006, Biochimica et biophysica acta.